The Patent Finder

Method for Inducing Immune Response Against Middle East Respiratory Syndrome-Corona Virus Using Trimeric S1-CD40L Fusion Protein

King Abdulaziz University

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 16/201,409, filed Nov 27, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,529,411Polynucleotide Encoding Trimeric S1-CD40L Fusion Protein Immunogen Against Middle East Respiratory Syndrome-Corona Virus
In force
 · Medium confidence
UsedRemaining
King Abdulaziz UniversityIn forceMedium confidence
US 11,660,334Method for Inducing Immune Response Against Middle East Respiratory Syndrome-Corona Virus Using Trimeric S1-CD40L Fusion Protein
In force
 · High confidence
King Abdulaziz UniversityIn forceHigh confidence
US 10,806,784Composition and Method for Treating Mers
Lapsed Oct 20, 2024 on the fee record
High confidence
King Abdulaziz UniversityLapsed Oct 20, 2024 on the fee recordHigh confidence
US 10,849,972Trimeric S1-CD40L Fusion Protein Vaccine Against Middle East Respiratory Syndrome-Coronavirus
Lapsed Dec 1, 2024 on the fee record
High confidence
King Abdulaziz UniversityLapsed Dec 1, 2024 on the fee recordHigh confidence
US 11,154,612MERS-CoV VACCINE WITH TRIMERIC S1-CD40L FUSION PROTEIN
Lapsed Oct 26, 2025 on the fee record
High confidence
King Abdulaziz UniversityLapsed Oct 26, 2025 on the fee recordHigh confidence
US 11,219,685INTRANASAL MERS-CoV VACCINE
Lapsed Jan 11, 2026 on the fee record
High confidence
King Abdulaziz UniversityLapsed Jan 11, 2026 on the fee recordHigh confidence
US 11,305,008Nucleic Acid Based Vaccine Against Middle East Respiratory Syndrome-Coronavirus
Lapsed Apr 19, 2026 on the fee record
High confidence
King Abdulaziz UniversityLapsed Apr 19, 2026 on the fee recordHigh confidence
US 11,318,198MERS-CoV VACCINE COMPOSITION
Lapsed May 3, 2026 on the fee record
High confidence
King Abdulaziz UniversityLapsed May 3, 2026 on the fee recordHigh confidence
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by King Abdulaziz University.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited